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Abstract
Aims: This study used a large database to develop a reliable and valid shortened form 
of the Edinburgh Postnatal Depression Scale (EPDS), a self-report questionnaire used 
for depression screening in pregnancy and postpartum, based on objective criteria.
Methods: Item responses from the 10-item EPDS were obtained from 5157 par-
ticipants (765 major depression cases) from 22 primary screening accuracy stud-
ies that compared the EPDS to the Structured Clinical Interview for DSM (SCID). 
Unidimensionality of the EPDS latent construct was verified using confirmatory fac-
tor analysis, and an item response theory model was fit. Optimal test assembly (OTA) 
methods identified a maximally informative shortened form for each possible scale 
length between 1 and 9 items. The final shortened form was selected based on pre-
specified validity and reliability criteria and non-inferiority of screening accuracy of 
the EPDS as compared to the SCID.
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Results: A 5-item short form of the EPDS (EPDS-Dep-5) was selected. The EPDS-
Dep-5 had a Cronbach's alpha of 0.82. Sensitivity and specificity of the EPDS-Dep-5 
for a cutoff of 4 or greater were 0.83 (95% CI, 0.73, 0.89) and 0.86 (95% CI, 0.80, 
0.90) and were statistically non-inferior to the EPDS. The correlation of total scores 
with the full EPDS was high (r = 0.91).
Conclusion: The EPDS-Dep-5 is a valid short form with minimal loss of informa-
tion when compared to the full-length EPDS. The EPDS-Dep-5 was developed with 
OTA methods using objective, pre-specified criteria, but the approach is data-driven 
and exploratory. Thus, there is a need to replicate results of this study in different 
populations.
K E Y W O R D S
depression, optimal test assembly, patient-reported outcome, short form
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1 |  INTRODUCTION
Depression is a leading cause of disability among women.1 
Although the 7–13% prevalence of major depression dur-
ing pregnancy and postpartum2–5 is similar to rates among 
women during non-childbearing periods,3,6–10 perinatal de-
pression is associated with adverse outcomes for the mother, 
developing child, mother-infant relationship and marital 
quality.11–13 Most women with depression in the perinatal 
period, however, do not receive adequate care.14–16 Rapidly 
identifying women with depression to improve their care is a 
high clinical priority.17
The 10-item Edinburgh Postnatal Depression Scale 
(EPDS) is the most commonly used self-report question-
naire in pregnancy and postpartum for screening, and it is 
also used as a continuous scale for symptom monitoring 
clinically and for research.16,18 Scores on each EPDS item 
reflect the frequency of symptoms in the last two weeks 
and range from 0 to 3, with questions 3 and 5–10 reverse 
coded. Total scores range from 0 to 30. Higher scores in-
dicate greater depressive symptomatology. As completing 
measures can be demanding, shortened versions with scores 
that perform comparably well with original full-length ver-
sions may help reduce the burden placed on respondents, 
as well as decrease the time it takes to administer the scale. 
However, shortening a scale is only advisable if it does 
not adversely affect measurement and screening accuracy 
properties of the scale.
Shortened forms of the full 10-item EPDS have been 
developed Table  1.19–24 These include two two-item 
forms,19,24 a five-item form,20 three- and seven-item sub-
scales that measure symptoms of anxiety and depression 
separately,21,24 a three-item form,22 and an eight-item 
form.23 None of the development processes for these short-
ened forms used pre-specified criteria for performance to 
determine how many items to remove from the full 10-item 
EPDS. Furthermore, only three studies shortening the 
EPDS validated against major depression classification 
status,20,22,24 and these studies included only 63, 19, and 
9 major depression cases. The extent to which the exist-
ing shortened forms retain the measurement and diagnostic 
properties of the full scale is unclear. Individual participant 
data meta-analysis (IPDMA), in which participant-level 
data from many studies are synthesized, allows for the 
development of a shortened form using data from a large 
number of participants.
Optimal test assembly (OTA) is a mixed-integer pro-
gramming procedure that uses an estimated item response 
theory (IRT) model to select the subset of items that maxi-
mizes performance with respect to a given metric while sat-
isfying pre-specified constraints.25 While more commonly 
Significant Outcomes
• A 5-item short form of the EPDS can be used to 
screen for depression in the perinatal period.
• The 5-item short form was shown to be valid and 
reliable in a sample of 5157 participants.
• Optimal test assembly methods provide a repli-
cable and reproducible methodology to shorten 
patient-reported outcomes.
Limitations
• This study was not able to obtain data from 25 of 
81 eligible datasets.
• There exists substantial heterogeneity across stud-
ies in terms of country and language of adminis-
tration of the semi-structured interview.
• The optimal test assembly procedure is data-
driven and should be replicated.
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used in the development of high-stakes educational tests,26 
OTA is being increasingly used to develop shortened ver-
sions of patient-reported outcome measures.27–29 This pro-
cedure was also shown to be replicable, reproducible, and 
to produce shortened forms of minimal length compared to 
alternative methods.30
1.1 | Aims of the study
The objective of the present study was to apply optimal test 
assembly methods to a large database in order to develop 
a shortened version of the Edinburgh Postnatal Depression 
Scale. We (1) used confirmatory factor analysis to verify the 
unidimensionality of the underlying construct measured by 
the Edinburgh Postnatal Depression Scale; (2) applied opti-
mal test assembly methods to obtain candidate forms of each 
possible length; and (3) selected the shortest possible form 
that showed similar performance to the full form in terms of 
pre-specified validity, reliability, and screening accuracy cri-
teria, compared to the Edinburgh Postnatal Depression Scale.
2 |  MATERIALS AND METHODS
This study used a subset of data accrued for an IPDMA on the 
diagnostic accuracy of the EPDS for screening to detect major 
depression among pregnant and postpartum women. This 
IPDMA was registered in PROSPERO (CRD42015024785) 
and a protocol was published.31 The protocol for the main 
IPDMA did not include methods for the present study. A pro-
tocol for the present study was uploaded to the Open Science 
Framework repository prior to initiating the study (https://
osf.io/3cepr/).
2.1 | Study eligibility for the main IPDMA
Datasets from articles in any language were eligible if they 
included women ≥18 years who were pregnant or had given 
birth in the previous year and both: (a) EPDS scores and 
(b) diagnostic classification for a current Major Depressive 
Episode (MDE) using Diagnostic and Statistical Manual 
of Mental Disorders (DSM) or International Classification 
of Diseases (ICD) criteria based on a validated semi-struc-
tured or fully structured interview, administered within two 
weeks of each other. Participants recruited from psychiatric 
settings or setting where scales or interviews were admin-
istrated because of reported symptoms of depression were 
excluded, since screening is done to identify previously un-
recognized cases.32 Not all participants in a dataset needed 
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2.2 | Database searches and study selection
A medical librarian searched Medline, Medline In-Process & 
Other Non-Indexed Citations and PsycINFO via OvidSP, and 
Web of Science Core Collections via ISI Web of Knowledge 
from inception to October 3, 2018, using a peer-reviewed33 
search strategy (Methods S1). We reviewed reference lists 
of relevant reviews and queried contributing authors about 
non-published studies. Search results were uploaded into 
RefWorks (RefWorks-COS). After de-duplication, remain-
ing citations were uploaded into DistillerSR (Evidence 
Partners) for processing review results.
Two investigators independently reviewed titles and ab-
stracts. If either deemed a study potentially eligible, full-text 
review was done by two investigators, independently, with 
disagreements resolved by consensus, consulting a third in-
vestigator when necessary.
2.3 | Data contribution, 
extraction, and synthesis
Authors of eligible datasets were invited to contribute de-
identified primary data, including EPDS item scores and 
major depression status. We emailed corresponding authors 
of eligible primary studies at least three times, as necessary. 
If there was no response, we emailed co-authors and at-
tempted phone contact.
Individual participant data were converted to a standard 
format and synthesized into a single dataset. We compared 
published participant characteristics and accuracy results 
with results from raw datasets and resolved any discrepancies 
in consultation with primary investigators.
For defining major depression, we considered MDD 
or MDE based on the DSM or ICD. If more than one was 
reported, we prioritized MDE over MDD. This is because 
screening would attempt to detect depressive episodes; fur-
ther interview would determine if the episode is related to 
MDD, bipolar disorder, or persistent depressive disorder. We 
also prioritized DSM over ICD.
When datasets included statistical weights to reflect sam-
pling procedures, we used the provided weights. For studies 
where sampling procedures merited weighting (e.g., all par-
ticipants with positive screens and a random subset of partic-
ipants with negative screens received a diagnostic interview), 
but the original study did not weight, we used inverse selec-
tion probabilities.
2.4 | Data eligibility for present study
For the present study, from the main IPDMA dataset, 
we only included primary studies that classified major 
depression based on the Structured Clinical Interview for 
DSM (SCID).34 The SCID is a semi-structured diagnostic 
interview that was designed to be conducted by experienced 
diagnosticians. It requires clinical judgment and allows re-
phrasing questions and probes to follow up responses. Fully 
structured interviews, on the other hand, are fully scripted, 
with no allowance for deviation from the script. These in-
terviews remove clinical judgement from the process, al-
lowing lay interviewers, rather than clinicians, to perform 
the assessment. Because of this, they may sacrifice validity. 
In recent analyses using three large IPDMA databases,35–37 
it was found that compared to semi-structured interviews, 
fully structured interviews, which are designed for adminis-
tration by lay interviewers, may identify more patients with 
low-level symptoms as depressed but fewer patients with 
high-level symptoms. Furthermore, a very brief version, the 
Mini International Neuropsychiatric Interview, identified 
far more participants as being depressed across the symp-
tom spectrum.35-37 These results were consistent with the 
idea that semi-structured interviews most closely replicate 
clinical interviews done by trained professionals, whereas 
fully structured interviews are less rigorous reference stand-
ards. They are less resource-intensive options that can be 
administered by research staff without diagnostic skills but 
may misclassify major depression in substantial numbers 
of patients. Semi-structured interviews replicate diagnos-
tic standards more closely than other types of interviews, 
and the SCID is by far the most commonly used semi-struc-
tured diagnostic interview for depression research [34–36]. 
In our main EPDS IPDMA database, 34 of 36 studies that 
used semi-structured interviews to classify major depression 
status used the SCID. Therefore, we only included SCID 
studies.
In addition, as EPDS item-level data was necessary for 
the proposed analyses, we only included studies in which 
EPDS item-level data (not just total scores) were available. 
For studies that collected data at multiple time points, we 
selected the time point with the most participants. If there 
was a tie, we selected the time point with the most major 
depression cases.
2.5 | Statistical analyses
All analyses were conducted using R version 3.6.0.
2.5.1 | Verification of 
unidimensionality of the EPDS
Robust weighted least squares estimation in R was used 
to fit a single-factor confirmatory factor analysis model 
of EPDS items.38 The model was first fit without allowing 
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for any residual correlations among the items. If there was 
poor model fit, and if warranted by theoretical justification, 
modification indices were to be used to identify item pairs 
that would improve model fit by allowing their residuals 
to correlate.39 Model fit was evaluated concurrently, using 
the χ2 statistic, Comparative Fit Index (CFI), Tucker-Lewis 
Index (TLI), and Root Mean Square Error of Approximation 
(RMSEA).40 Priority was given to CFI, TLI, and RMSEA, 
because the χ2 test may reject well-fitting models when 
sample size is large.41 Model fit was considered to be ad-
equate if CFI and TLI were ≥0.95 and RMSEA ≤0.08.42 
The confirmatory factor analysis was fit using the lavaan 
package.43
2.5.2 | Item response theory model and optimal 
test assembly
A generalized partial credit model (GPCM) was fit to EPDS 
pooling data from all included studies.44 The GPCM is an 
IRT model that relates a latent trait, representing severity of 
depressive symptomatology, to the distribution of observed 
item-level responses. The GPCM estimates two types of 
item-specific parameters: a discrimination parameter and 
threshold parameters. From these item-level parameter esti-
mates, item information functions for each item were calcu-
lated from the GPCM, as well as a test information function 
(TIF), obtained by summing item information functions. 
Because the TIF is inversely related to the standard error of 
measurement of the latent trait, high amounts of information 
represent greater precision for measuring depressive symp-
tomatology. The GPCM was fit using the ltm package.45
Next, we used OTA—a mixed-integer programming tech-
nique—to systematically search for the short form that maxi-
mized the TIF, subject to the constraint of fixing the number 
of items included in each short form. By using the TIF as the 
objective function, the procedure optimizes the precision of 
the short form in estimating participants’ level of depressive 
symptomatology.25,46 The shape of the TIF was anchored at 
five points.25 Thus, for each short form of lengths 1–9 items, 
OTA selected items from the full set of EPDS items that max-
imized the test information. The OTA analysis was conducted 
using the lpSolveAPI package.
For each of the 9 candidate short forms and the full-length 
form, two scoring procedures were used to obtain estimates 
of each participant's level of depressive symptomatology. 
First, the summed scores across all items included in the 
short form were calculated. Second, factor scores were es-
timated for each participant. Although summed scores are 
typically relied upon for clinical use, the factor scores are 
considered to provide a better estimate of the latent trait be-
cause of well-known limitations of the summed score under 
the GPCM.47,48
2.5.3 | Selection of final short form
The elimination of items necessarily reduces information 
compared to a full-length form. Thus, to guarantee adequate 
performance, the selection of the final short form was based 
on the following five criteria: reliability, concurrent validity 
of summed scores, concurrent validity of factor scores, and 
non-inferior sensitivity and specificity.
Reliability of each candidate short form was assessed with 
Cronbach's alpha,49 since it is commonly used in research, de-
spite limitations. The final selected form was required a priori 
to have a Cronbach's alpha coefficient ≥0.80. Concurrent va-
lidity of the summed scores and factor scores was measured 
with the Pearson's correlation coefficient between candidate 
T A B L E  2  Patient demographic and diagnostic characteristics 
(N = 5157)
Sociodemographic variables Summary
Age, years, mean [median] ± SD (range) 29.1 [29] ± 5.9 
(18, 47)
















South Africa 104 (2.0)
Thailand 625 (12.1)
United Kingdom 1093 (21.2)
United States of America 239 (4.6)
Vietnam 359 (7.0)
Pregnancy status, n (%)
Pregnant 1455 (28.2)
Postpartum 3702 (71.8)
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short form scores and the full-length EPDS. It was required a 
priori to be ≥0.90.30
Diagnostic accuracy of each candidate short form was 
assessed through a three-step process. First, pooled sen-
sitivity and specificity of each candidate short form (com-
pared to the SCID) for each of its possible cutoff summed 
score values were estimated with a bivariate random-effects 
model. Second, for each candidate short form, an optimal 
cutoff score was selected using Youden's J statistic (sensitiv-
ity + specificity −1).50,51 The bivariate random-effects model 
was fit using the lme4 package.52
Third, two non-inferiority tests were conducted for each 
of the 9 candidate forms to compare sensitivity and specific-
ity, separately, to the full-length form. Non-inferiority tests 
assess whether the sensitivity or specificity of the short form 
is not lower than that of the full-length form, up to a pre-spec-
ified clinically significant tolerance of δ = 0.05.53 To con-
duct the non-inferiority test, the sampling distribution of the 
test statistic was generated through the bootstrap method.54 
Bootstrapping resamples the original dataset with replace-
ment to generate new, artificial, datasets.55 For each non-in-
feriority test, 2000 bootstrap iterations were conducted, 
controlling in each for the number of respondents with and 
without major depression. For each bootstrap iteration, the 
bivariate random-effects model was fit to each of the 9 can-
didate short forms and the full-length form, and the sensitiv-
ities and specificities were computed based on their cutoff 
scores. To account for the multiple testing in the 18 total 
non-inferiority tests, Benjamini-Hochberg adjusted p-values 
were used to determine the significance of the tests at the 
0.05 significance level.56
2.6 | Funding and ethics
The study sponsors had no role in study design; in the collec-
tion, analysis, and interpretation of data; in the writing of the 




1 I have been able to laugh and see the funny side of 
things
1.69
2 I have looked forward with enjoyment to things 1.51
3 I have blamed myself unnecessarily when things 
went wrong
1.04
4 I have been anxious or worried for no good reason 1.13
5 I have felt scared or panicky for no very good reason 1.16
6 Things have been getting on top of me 1.11
7 I have been so unhappy that I have had difficulty 
sleeping
1.39
8 I have felt sad or miserable 3.00
9 I have been so unhappy that I have been crying 2.57
10 The thought of harming myself has occurred to me 1.29
T A B L E  3  EPDS items and 
discrimination parameters from the 
generalized partial credit model
F I G U R E  1  The left-hand plot shows the item information functions for each of the 10 items. The right-hand plot shows the test information 
function of the EPDS
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DH had full access to all data in the study and had final re-
sponsibility for the decision to submit for publication. As this 
study involved secondary analysis of de-identified previously 
collected data, the Research Ethics Committee of the Jewish 
General Hospital declared that this project did not require re-
search ethics approval. However, for each included dataset, 
we confirmed that the original study received ethics approval 
and that all patients provided informed consent.
3 |  RESULTS
3.1 | Search results and inclusion of primary 
data
Of 4434 unique titles and abstracts identified from the da-
tabase search, 4056 were excluded after title and abstract 
review and 257 after full-text review, leaving 121 eligible 
articles with data from 81 unique participant samples, of 
which 56 (69%) contributed datasets (Figure S1. Authors of 
included studies contributed data from two additional studies 
that were not retrieved by the search, for a total of 58 data-
sets. Of these, we excluded 24 studies that used a diagnostic 
interview other than the SCID and 12 more studies that did 
not have EPDS item scores available. In total, 5157 partici-
pants (765 major depression cases) from 22 primary studies 
were included. These studies were conducted in 18 different 
countries, with 17 different languages. The mean age of the 
sample was 29.1 years. See Table 2 for descriptive sample 
statistics and Table S1 for characteristics of each included 
study.
3.2 | Unidimensionality of the EPDS
A single-factor model was fit to the EPDS-10 with residuals 
modeled as uncorrelated (χ2 [df =65] = 663.1, p < 0.0001, 
TLI =0.992, CFI =0.988, RMSEA =0.042). As this model 
was deemed to be well fitting, no modification indices were 
used. Factor loadings for items were all high, with a median 
of 0.97 and a range of 0.88 to 1.15.
3.3 | Item response theory model and 
optimal test assembly
The discrimination parameters for each item based on the 
GPCM are presented in Table 3. The information functions 
of each of the 10 items, as well as the total TIF are shown in 
Figure 1. The item with the greatest discrimination parameter 
was item 8, and thus has the most peaked information func-
tion in Figure 1. Other items with high values of the discrimi-
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items 1, 2 and 9. Table 4 shows the items that were included 
in each of the 9 candidate short forms from the OTA analysis. 
Item 8 was included in all candidate short forms, with items 
3, 5, and 6 quickly dropped.
3.4 | Selection of final short form
Cronbach's alpha values and concurrent validity correlations 




Correlation of summed 
scores (95% CI)
Correlation of factor 
scores (95% CI)
1 NA 0.816 (0.807, 0.825) NA
2 0.811 (0.797, 
0.823)
0.867 (0.860, 0.874) 0.913 (0.841, 0.953)
3 0.805 (0.794, 
0.815)
0.891 (0.885, 0.897) 0.932 (0.875, 0.963)
4 0.833 (0.823, 
0.841)
0.899 (0.894, 0.904) 0.945 (0.898, 0.970)
5 0.818 (0.808, 
0.827)
0.910 (0.906, 0.915) 0.949 (0.906, 0.973)
6 0.840 (0.832, 
0.848)
0.932 (0.928, 0.935) 0.962 (0.930, 0.980)
7 0.844 (0.837, 
0.851)
0.965 (0.963, 0.967) 0.975 (0.953, 0.987)
8 0.856 (0.850, 
0.862)
0.980 (0.979, 0.981) 0.988 (0.977, 0.993)
9 0.868 (0.862, 
0.874)
0.991 (0.990, 0.991) 0.997 (0.993, 0.998)
10 0.877 (0.872, 
0.883)
1.000 (1.000, 1.000) 1.000 (1.000, 1.000)
Note: Bold values represent those of the final selected form.
T A B L E  5  Reliability and validity 








1 2 0.612 (0.525, 
0.693)
1.000 0.917 (0.884, 
0.941)
0.000
2 3 0.654 (0.563, 
0.735)
1.000 0.919 (0.887, 
0.943)
0.000
3 3 0.801 (0.707, 
0.870)
0.001 0.823 (0.762, 
0.871)
0.822
4 4 0.782 (0.670, 
0.863)
0.022 0.872 (0.819, 
0.912)
0.000
5 4 0.825 (0.731, 
0.892)
0.000 0.859 (0.801, 
0.902)
0.000
6 5 0.803 (0.720, 
0.866)
0.000 0.870 (0.811, 
0.913)
0.000
7 7 0.799 (0.705, 
0.869)
0.005 0.892 (0.833, 
0.931)
0.000
8 8 0.834 (0.751, 
0.893)
0.000 0.863 (0.799, 
0.909)
0.000
9 9 0.822 (0.739, 
0.882)
0.000 0.857 (0.793, 
0.904)
0.000
10 11 0.797 (0.710, 
0.863)
NA 0.880 (0.826, 
0.919)
NA
Note: Bold values represent those of the final selected form.
T A B L E  6  Screening accuracy results 
of the candidate short forms and their non-
inferiority test results
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results of the non-inferiority tests for both sensitivity and 
specificity are presented in Table 6.
The 5-item short form (EPDS-Dep-5) was the shortest 
form that fulfilled all criteria. The form included item 1 (“I 
have been able to laugh and see the funny side of things”), 
item 2 (“I have looked forward with enjoyment to things”), 
item 8 (“I have felt sad or miserable”), item 9 (“I have been so 
unhappy that I have been crying”), and item 10 (“The thought 
of harming myself has occurred to me”). The EPDS-Dep-5 
maintained high reliability with a Cronbach's alpha of 0.82 
(95% CI, 0.81, 0.83) compared to 0.88 (95% CI, 0.87, 0.88) 
for the full-length form. Correlations of the summed and fac-
tor scores between the EPDS-Dep-5 and EPDS-10 were 0.91 
(95% CI, 0.91, 0.92) and 0.95 (95% CI, 0.91, 0.97), respec-
tively. Youden's J for the full EPDS and EPDS-Dep-5, at their 
optimal cutoffs of 11 or greater and 4 or greater, respectively, 
were both 0.68. Receiver operating curves for the full EPDS 
and EPDS-Dep-5 are presented in Figure S2. The sensitivity 
and specificity of the EPDS-Dep-5 at its optimal cutoff of 
4 or greater were 0.83 (95% CI, 0.73, 0.89) and 0.86 (95% 
CI, 0.80, 0.90), respectively. Both sensitivity and specificity 
were non-inferior to the sensitivity (0.80; 95% CI, 0.71, 0.86) 
and specificity (0.88; 95% CI, 0.83, 0.92) of the full-length 
form.
4 |  DISCUSSION
This study used OTA to shorten the EPDS to a 5-item 
shortened version (EPDS-Dep-5) while maintaining com-
parable measurement properties and screening accuracy to 
detect major depression among women in pregnancy and 
postpartum. The implication of this research is that short-
ening this scale allows for shorter administration times and 
places lower burden on respondents without significantly 
reducing the ability of the scale to measure depressive 
symptomology.
The EPDS-Dep-5 maintained similar sensitivity and 
specificity to that of the full-length form and resulted in a 
minimal loss of information. Furthermore, the shortened 
form maintained reliability and validity that were compa-
rable to the full-length form based on pre-specified criteria. 
Cronbach's alpha of the EPDS-Dep-5 was within 0.06 of 
that for the full-length form, and correlations of the summed 
score and factor scores of the EPDS-5 and EPDS-10 were 
0.91 and 0.95. Per pre-specified criteria, the sensitivity and 
specificity of the EPDS-Dep-5 (0.825 and 0.859, respec-
tively) were non-inferior to those of the EPDS-10 (0.797 and 
0.880, respectively).
The 5 items included in the EPDS-Dep-5 included items 
1, 2, 8, 9, and 10 from the original EPDS. These items cover 
the two core symptoms of depression—low mood (items 8 
and 9) and anhedonia (items 1 and 2), as well as self-harm 
(item 10). Of note, although they were included as potential 
items for the final shortened form, none of the 3 anxiety items 
(items 3 [blame], 4 [anxious], and 5 [scared]) were retained 
in the EPDS-Dep-5. Our short form selection procedure as-
sessed screening accuracy for detecting depression, not anxi-
ety, and short form development for that purpose would need 
to be done separately.
Most existing studies developing shortened EPDS forms 
compared the shortened forms to the full EPDS rather than 
comparing to diagnostic classification for depression. Only 
three studies validated their shortened forms against major 
depression classification based on DSM or ICD diagnostic 
criteria, but these studies included only 63, 19, and 9 major 
depression cases,20,22,24 limiting their ability to draw con-
clusions about the shortened scales’ measurement proper-
ties. Table  1 presents the items included in each study's 
shortened form as well as the methods used to create that 
version. The development of the EPDS-Dep-5 in the pres-
ent study used data that originated from an IPDMA thus (1) 
providing the largest total sample size (5157 participants), 
as well as data from multiple settings and countries, (2) 
used by far the largest number of major depression cases 
(765 cases), (3) used a validated semi-structured diagnostic 
interview as the reference standard for major depression 
classification (the SCID), and (4) used screening accuracy 
as part of the development process, not solely as a tool for 
validation. It was also the only study that used objective, 
pre-specified criteria for empirical selection of items to in-
clude in the short form.
This study showed that an EPDS-Dep-5 cutoff ≥4 max-
imized combined sensitivity and specificity using Youden's 
J.51 However, clinicians and researchers may consider use of 
a higher cutoff if their goal is to only capture patients with 
high depressive symptom levels or a lower cutoff if their goal 
is to avoid false negatives.
There are several limitations for this study that must 
be considered. First, for the collection of data for the full 
IPDMA, it was not possible to obtain primary data from 
25 of the 81 eligible datasets. In addition, of the 34 studies 
using the SCID that provided data for the full IPDMA, 12 
did not provide EPDS item scores and thus could not be in-
cluded in the present study. Second, although we included 
data from 22 studies that fulfilled strict inclusion criteria, in-
cluding the use of the rigorous semi-structured SCID inter-
view, there was still substantial heterogeneity across studies 
in terms of country and language which both allows for the 
generalization of the results to larger and more diverse pop-
ulations but also may not select the optimal shortened form 
for each individual context. Third, the present study did not 
conduct a risk of bias assessment; however, the full IPDMA 
from which a subset of data was selected for this study did 
conduct a risk of bias assessment using QUADAS-2. No 
QUADAS-2 domain items were consistently associated 
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with differences in sensitivity or specificity estimates. 
Furthermore, the OTA procedure, is a data-driven approach, 
and therefore the results of this study should be replicated or 
cross-validated. Lastly, future work may consider assessing 
whether the EPDS-Dep-5 is subject to issues of poor item fit 
or differential item functioning.
5 |  CONCLUSION
The study used the OTA method to develop a valid and reli-
able 5-item shortened form of the EPDS using pre-specified 
objective criteria to determine the length and items included 
in the EPDS-Dep-5. This method was implemented with a 
sample of 5157 participants from 22 primary studies. The 
resulting 5-item shortened version maintained measurement 
properties and screening accuracy of the full-length form 
within pre-specified limits.
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